The $35 Prescription Cliff: New Study Reveals Tipping Point for Medication Abandonment

FORT WALTON BEACH, Fla. – May 19, 2026 – A new study has pinpointed a startlingly low price at which millions of Americans may be forced to abandon their prescribed medications: $35. Research released today by healthcare technology company Buzz Health reveals that the rate at which patients fill prescriptions plummets dramatically once their out-of-pocket cost crosses this threshold, signaling a critical breakdown in medication access that affects nearly half the population.

The Buzz Health Prescription Consumer Behavioral Study found that a staggering 49% of patients have previously walked away from a pharmacy counter without their medication due to cost. The research, which surveyed 210 patients nationwide, quantifies the precise financial tipping point. While 89% of patients said they would fill a prescription costing $15, that number falls to just 53% when the price hits $35. This 37-percentage-point drop is the steepest decline observed across all price points tested, revealing a definitive line where affordability ends and abandonment begins for a vast number of people.

“The prescription journey is shaped by moments where even small cost differences determine whether a patient stays on therapy or walks away,” said Joseph Kleiman, President of Buzz Health, in the press release. The findings suggest that for many, the decision to forgo essential treatment for conditions like diabetes, heart disease, or asthma isn't a matter of hundreds of dollars, but tens.

A Nationwide Problem Quantified

The study's findings, while based on a modest sample size, provide a stark numerical anchor to a problem pharmacists and doctors witness daily. Above the $35 mark, more patients abandon their prescriptions than fill them. When costs exceed $60, the study indicates that between two-thirds and 80% of patients choose to delay or forgo filling their prescriptions altogether. This phenomenon of “prescription abandonment” is a major driver of medication non-adherence, a public health crisis estimated to cause thousands of deaths and cost the U.S. healthcare system between $100 billion and $300 billion annually in avoidable hospitalizations and emergency care.

Independent data from pharmacy organizations corroborates the scale of the issue. A 2022 survey from the National Community Pharmacists Association (NCPA), for instance, found that nearly 80% of pharmacists reported seeing an increase in patients abandoning prescriptions, with the average pharmacy seeing dozens of scripts go unfilled each week due to cost. The Buzz Health research adds a crucial layer of understanding by identifying the specific price sensitivity that drives these decisions.

“This research reinforces that pricing transparency alone is only part of the equation,” Kleiman stated. “The real opportunity is ensuring patients and the healthcare professionals guiding them can see every available option at the exact moment cost becomes the deciding factor.”

The Unexpected Vulnerability of the Insured

Perhaps one of the most sobering findings is that having health insurance offers little protection from this affordability cliff. The study highlights the precarious position of patients enrolled in high-deductible health plans (HDHPs), a group that has grown substantially over the past decade. These individuals often face the full, undiscounted price of medications until their annual deductible—which can be thousands of dollars—is met.

The research showed that patients who have previously paid full price before meeting their deductible were 13% less likely to fill prescriptions priced at $60 or more. This makes them significantly more vulnerable to abandoning care during these high-deductible periods, effectively rendering them uninsured for routine prescription costs. This reality is compounded by a lack of price predictability; 59% of all survey respondents reported having been surprised by the final price of a medication at the pharmacy counter, a moment of “sticker shock” that often leads directly to abandonment.

This gap between being insured and being able to afford care underscores a systemic flaw in modern health plan design. As cost-sharing mechanisms like deductibles and copays become more complex, patients are increasingly shouldering a financial burden that their coverage was ostensibly designed to prevent, forcing them into impossible choices between their health and their finances.

Beyond Coupons: The Shift to Integrated Transparency

When faced with an unaffordable prescription, the study reveals a telling pattern in patient behavior. The majority do not turn to Google or discount apps. Instead, they turn to their trusted care team: 51% said they would ask their doctor for a lower-cost alternative, and 38% would consult their pharmacist. Only 25% reported that they would independently search online for coupons or discounts.

This insight challenges the prevailing direct-to-consumer model of prescription savings, which relies on patients to proactively hunt for the best price. The data suggests a more effective solution lies not in patient-led searches, but in empowering the healthcare professionals they already trust. The demand for such tools is significant, with related industry research showing that over 90% of prescribers find it extremely valuable to see both insurance and discount pricing options side-by-side within their electronic health record (EHR) workflow at the point of care.

The healthcare technology industry is beginning to pivot toward this integrated model. Rather than placing the burden of price discovery on the patient at the pharmacy, new solutions aim to provide real-time cost information directly to the doctor during the prescribing process. This allows for a proactive conversation about cost and the selection of an affordable therapy from the outset, preventing the downstream sticker shock and prescription abandonment that plagues the current system.

This shift marks a move away from reactive discounts and toward proactive, embedded price transparency. As prescription pricing becomes increasingly fragmented across a complex web of insurers, pharmacy benefit managers (PBMs), and discount programs, the ability to surface the most affordable option for a specific patient in real time is becoming the next frontier in improving medication adherence and overall public health.